Viking Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viking Therapeutics Inc
TickerVKTX
CIK #0001607678
CUSIP92686J106
SectorLife Sciences - Pharmaceutical Preparations
Address4370 La Jolla Village Drive, Suite 400, La Jolla, CA 92122
Source [EDGAR]
CIK Filing 2011 - 2024
[0001607678] 10-K
[0001607678] 10-Q
[0001607678] 3
[0001607678] 4
[0001607678] 8-K
[0001607678] D
[0001607678] SC 13D
[0001607678] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Viking Therapeutics Inc [2023-04-10] 0.0
Millennium Management LLC Viking Therapeutics Inc [2023-01-03] 6.3
BlackRock Inc Viking Therapeutics Inc [2022-07-08] 1.8
State Street Corp Viking Therapeutics Inc [2021-02-11] 6.95
ArrowMark Colorado Holdings LLC Viking Therapeutics Inc [2019-02-14] 5.31
State Street Corp Viking Therapeutics Inc [2019-02-13] 9.5
BlackRock Inc Viking Therapeutics Inc [2019-02-08] 5.7
FMR LLC Viking Therapeutics Inc [2018-10-10] 0.0
Boxer Capital LLC Viking Therapeutics Inc [2018-02-12] 0.0
Farwell Grosvenor Nicholas Viking Therapeutics Inc [2017-12-19] 7.8
Sphera Funds Management Ltd Viking Therapeutics Inc [2017-12-18] 7.43
LIAN Brian Viking Therapeutics Inc [2016-02-16] 15.2
Dinerman Michael Viking Therapeutics Inc [2016-02-16] 6.1
Ligand Pharmaceuticals Inc Viking Therapeutics Inc [2015-05-08] 49.8
Form 3/4/5 Filer 2011 - 2024
Viking Therapeutics, Inc.
Rowland Charles A Jr
Macartney Lawson
Lian Brian
Zante Greg
Mancini Marianna
Foehr Matthew W
Rouan Sarah Kathryn
Singleton J Matthew
Morneau Michael
Ligand Pharmaceuticals Inc
Webster Stephen W
Masamune Hiroko
Hanley Rochelle
Dinerman Michael
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 10,921,578.0 10,922,748.0
State Street Corp [2023-03-31] DFND 5,269,544.0 5,280,944.0
Millennium Management LLC [2023-03-31] SOLE 3,837,996.0 4,404,296.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,976,087.0
Susquehanna International Group LLP [2023-03-31] DFND 1,343,308.0 2,484,708.0
BlackRock Inc. [2023-03-31] SOLE 1,989,606.0 2,040,278.0
Boxer Capital, LLC [2023-03-31] OTR 2,000,000.0 2,000,000.0
Viking Global Investors LP [2023-03-31] SOLE 1,955,063.0 1,955,063.0
Wasatch Advisors LP [2023-03-31] SOLE 1,507,239.0 1,705,444.0
Laurion Capital Management LP [2023-03-31] SOLE 1,697,352.0 1,697,352.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 1,393,335.0
Deerfield Management Company LP Series C [2023-03-31] DFND 1,125,000.0 1,125,000.0
Great Point Partners LLC [2023-03-31] DFND 0.0 1,080,000.0
Cormorant Asset Management LP [2023-03-31] DFND 1,050,000.0 1,050,000.0
Citadel Advisors LLC [2023-03-31] DFND 1,039,292.0 1,039,292.0
RTW Investments LP [2023-03-31] SOLE 1,000,000.0 1,000,000.0
Two Sigma Advisers LP [2023-03-31] SOLE 832,028.0 896,528.0
Morgan Stanley [2023-03-31] DFND 555,896.0 878,611.0
Perceptive Advisors LLC [2023-03-31] SOLE 871,747.0 871,747.0
Goldman Sachs Group Inc [2023-03-31] DFND 869,956.0 869,986.0
Geode Capital Management LLC [2023-03-31] DFND 863,232.0 863,232.0
Bank of America Corp /DE/ [2023-03-31] DFND 10,721.0 858,245.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 840,655.0 850,055.0
Renaissance Technologies LLC [2023-03-31] SOLE 761,200.0 761,200.0
Integral Health Asset Management LLC [2023-03-31] SOLE 727,100.0 727,100.0
Affinity Asset Advisors LLC [2023-03-31] SOLE 716,149.0 716,149.0
Two Sigma Investments LP [2023-03-31] SOLE 695,705.0 695,705.0
Ghost Tree Capital LLC [2023-03-31] SOLE 600,000.0 600,000.0
683 Capital Management LLC [2023-03-31] DFND 580,000.0 580,000.0
Citigroup Inc [2023-03-31] DFND 565,041.0 565,041.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com